Navigation Links
DCL Extends Structured Product Labeling (SPL) Services to Meet New FDA Requirements; Support Now Offered for CDER, CBER, CDRH, CVM and ONP Products
Date:10/30/2008

Data Conversion Laboratory, Inc. (DCL) (www.dclab.com), announced the availability of enhanced Structured Product Labeling (SPL) services to meet the recently announced FDA requirements for SPL submissions of CDER (Human Prescription Drugs), CBER (Biologics), CDRH (Medical Devices), CVM (Veterinary Medicine), and ONP (Over-the-Counter) products.

Philadelphia, PA, and New York, NY (PRWEB) October 30, 2008 -- Data Conversion Laboratory, Inc. (DCL) (www.dclab.com), a leader in conversion services to pharmaceutical and health care organizations, announced the availability of enhanced Structured Product Labeling (SPL) services to meet the recently announced FDA requirements for SPL submissions of CDER (Human Prescription Drugs), CBER (Biologics), CDRH (Medical Devices), CVM (Veterinary Medicine), and ONP (Over-the-Counter) products.

While SPL has been required for CDER products for three years, the FDA is expanding the requirements to include Establishment Registration and NDC Labeler Code Requests. In addition, the FDA announced the requirement of SPL submissions for other FDA divisions (Animal and Veterinary Health, Biologics, Medical Devices and Over-the-Counter).

The extended services allow DCL customers to be fully compliant with FDA guidance without the need for extensive in-house expertise.

Howard Shatz, DCL's SPL Project Manager, notes that "Besides expanding the range of products requiring SPL, the FDA has also expanded the supporting information needed for a label submission. As we have done with SPL all along, we are making it as simple as possible for sponsors to have a fully compliant submission without the hassle."

"We are focused on providing customers with a complete solution that allows rapid compliance with FDA guidance without need for them to build an in-house staff. This expansion, beyond human prescription drug sponsors, reflects our commitment to provide customers more value in their regulatory efforts," said Mark Gross, DCL's President. "Customers love the ease and convenience of our SPL service, and we look forward to enhancing services and offering customers best-in-class SPL conversion efforts for these additional products."

About Data Conversion Laboratory, Inc.
Data Conversion Laboratory, Inc. is a leading provider of conversion services for mission critical applications. In health sciences DCL works with over 125 sponsors worldwide to facilitate compliance with the FDA's SPL initiative. Having completed over 2000 SPL conversions, DCL has worked with more sponsors for SPL conversions than all other vendors combined.

Media Contact:
Don Bridges, Data Conversion Laboratory, Inc.
505.275.2223, dbridges @ dclab.com

# # #

Read the full story at http://www.prweb.com/releases/2008/10/prweb1544754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. FTC Extends Final Red Flag Compliance Deadline for Creditors
2. World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center
3. Highmark Foundation Extends Subsidy for Health eTools for Schools(R) through 2013
4. Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
5. City of Tempe, Arizona Extends Contract with U.S. Preventive Medicine for Employee Health Management Program
6. Robotic surgery extends benefits to bladder cancer patients at NewYork-Presbyterian/Weill Cornell
7. MDdatacor Extends Contract with Wellmark, Inc.
8. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
9. Sun Pharma Extends Tender Offer for Taro
10. American Heart Association Extends Sympathy to Family of Journalist Tim Russert
11. Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The ... Drug Development through Molecular Imaging.” The focus of ADDMI-IG will be geared towards ... and development pipeline issues. Through ADDMI-IG WMIS will provide a platform for productive ...
(Date:5/25/2016)... Miami, FL (PRWEB) , ... May 25, 2016 , ... ... deep dive into the unique integrative medical wellness offerings of Europe, a continent that ... in Tyrol, Austria will hear from numerous pioneers in medical wellness, including Henri Chenot, ...
(Date:5/25/2016)... ... ... Casa Velas, an adults-only boutique hotel in Puerto Vallarta, Mexico, introduces a ... wellness suites . The two 1,350 sq. ft. suites which debuted in late 2015 ... amenities, from a custom soap selection and in-suite exercise kit to a personal wellness ...
(Date:5/25/2016)... ... May 25, 2016 , ... America Walks , a ... M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public Health , ... Ms. Reichbaum and 24 other advocates from around the country to participate in a ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows users to ... said Christina Austin - CEO of Pixel Film Studios. , With the FCPX ... add stylish color grades to their footage. A LUT is a Lookup Table that ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Los innovadores de COMBO[TM], ... introduce catéteres para la intervención de extremidades inferiores ... global especializada en el suministro de soluciones vasculares ... incluyendo productos para tratar la enfermedad arterial periférica. ... los dispositivos de primera entrada de la compañía ...
(Date:5/24/2016)... , May 24, 2016 ... elkaar verbindt, zodat zij collectief patiënten kunnen behandelen, hun ... is het idee achter de nieuwe en revolutionaire MDLinking ... van de Nederlandse vaatchirurg dr. Hans Flu en oncologisch ... app, die inmiddels beschikbaar is, wordt op dinsdag 24 ...
(Date:5/23/2016)... York , May 23, 2016 ... report titled, " Exocrine Pancreatic Insufficiency Market - Global ... - 2023 ." According to the report, the exocrine ... CAGR of 8.3% from 2015 to 2023 to reach ... (EPI) is a condition characterized by the deficiency of ...
Breaking Medicine Technology: